Ho Carole (CIK 1724605) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy RPRX (4,545 shares), Sell DNLI (2,937 shares), Sell DNLI (806 shares), Buy DNLI (44,655 shares), Buy RPRX (2,752 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Royalty Pharma plc (RPRX) | Director | Buy | 4,545 | $0 |
| 2025-08-14 | Denali Therapeutics Inc. (DNLI) | Chief Medical Officer | Sell | 2,937 | $39,884 |
| 2025-08-14 | Denali Therapeutics Inc. (DNLI) | Chief Medical Officer | Sell | 806 | $11,800 |
| 2025-08-07 | Denali Therapeutics Inc. (DNLI) | Chief Medical Officer | Buy | 44,655 | $30,365 |
| 2025-07-31 | Royalty Pharma plc (RPRX) | Director | Buy | 2,752 | $0 |
| 2025-07-31 | Royalty Pharma plc (RPRX) | Director | Buy | 5,806 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08